We are live on ! Find out more
TXG icon

10x Genomics
TXG

104 hedge funds and large institutions have $2.45B invested in 10x Genomics in 2020 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 40 increasing their positions, 18 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

209% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 11

122% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 18

84% more call options, than puts

Call options by funds: $8.79M | Put options by funds: $4.77M

37.33% more ownership

Funds ownership: 147.35% → 184.68% (+37%)

22% more funds holding

Funds holding: 85 → 104 (+19)

20% more funds holding in top 10

Funds holding in top 10: 5 → 6 (+1)

4% more capital invested

Capital invested by funds: $2.35B → $2.45B (+$101M)

Holders
104
Holders Change
+19
Holders Change %
+22.35%
% of All Funds
2.29%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.13%
New
34
Increased
40
Reduced
18
Closed
11
Calls
$8.79M
Puts
$4.77M
Net Calls
+$4.02M
Net Calls Change
+$807K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$309M
2
SIAU
SB Investment Advisers (UK)
United Kingdom
+$299M
3
Invesco
Invesco
Georgia
+$61.7M
4
AllianceBernstein
AllianceBernstein
Tennessee
+$46.4M
5
CS
Credit Suisse
Switzerland
+$32.4M

Top Sellers

Rank Fund Capital Flow
1
FCMI
Foresite Capital Management I
California
-$113M
2
JCM
JS Capital Management
New York
-$20.4M
3
FCMI
Foresite Capital Management II
California
-$19.5M
4
Wells Fargo
Wells Fargo
California
-$11.9M
5
Capital World Investors
Capital World Investors
California
-$11.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
State Street
76
State Street
Massachusetts
$442K +$187K +2,400 +51%
Deutsche Bank
77
Deutsche Bank
Germany
$371K – – –
SEC
78
Seven Eight Capital
New York
$343K +$429K +5,500 New
TC
79
TwinBeech Capital
New York
$339K +$424K +5,435 New
SOMRS
80
State of Michigan Retirement System
Michigan
$285K +$357K +4,570 New
BM
81
Brandywine Managers
Delaware
$268K – – –
Aberdeen Group
82
Aberdeen Group
United Kingdom
$247K +$309K +3,958 New
MCCP
83
Mission Creek Capital Partners
California
$247K +$309K +3,958 New
GA
84
Greenspring Associates
Maryland
$214K +$267K +3,427 New
CIBC Asset Management
85
CIBC Asset Management
Ontario, Canada
$213K – – –
QSS
86
Quantitative Systematic Strategies
Florida
$209K +$262K +3,355 New
Osaic Holdings
87
Osaic Holdings
Arizona
$181K +$227K +2,911 New
Rockefeller Capital Management
88
Rockefeller Capital Management
New York
$138K +$173K +2,217 New
Russell Investments Group
89
Russell Investments Group
United Kingdom
$119K +$150K +1,922 New
Baillie Gifford & Co
90
Baillie Gifford & Co
United Kingdom
$99K +$124K +1,589 New
Royal Bank of Canada
91
Royal Bank of Canada
Ontario, Canada
$78K -$192K -2,459 -66%
Citigroup
92
Citigroup
New York
$48K +$20.9K +268 +54%
QT
93
Quantbot Technologies
New York
$43K +$54.6K +700 New
CG
94
Cutler Group
California
$37K +$39K +500 +500%
WPA
95
West Paces Advisors
Georgia
$28.4K – – –
VFA
96
Valeo Financial Advisors
Indiana
$16K – – –
US Bancorp
97
US Bancorp
Minnesota
$12K – – –
SFSIG
98
San Francisco Sentry Investment Group
California
$10K +$11.9K +153 New
Simplex Trading
99
Simplex Trading
Illinois
$9K -$16.3K -209 -57%
CSS
100
Cubist Systematic Strategies
Connecticut
$5K -$248K -3,183 -98%
1 2 3
4
5

TXG Hedge Fund Activity: Q1 2020 in Review

104 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in 10x Genomics (TXG) for Q1 2020, worth a combined $2.45B — up 4.3% from $2.35B a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new TXG positions and 11 closed out — a net gain of 23 holders — while 40 added to existing stakes and 18 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $309M. The largest seller was Foresite Capital Management I, cutting an estimated $113M.

  • 104 institutional investors held 10x Genomics (TXG) as of Q1 2020, up from 85 in Q4 2019.
  • Funds reported $2.45B of 10x Genomics stock for Q1 2020, up 4.3% quarter-over-quarter.
  • 34 funds opened new 10x Genomics positions in Q1 2020 and 11 closed out, a net change of +23 holders.
  • The largest 10x Genomics buyer in Q1 2020 was Morgan Stanley, an estimated $309M added.
  • The largest 10x Genomics seller in Q1 2020 was Foresite Capital Management I, an estimated $113M sold.

Based on aggregated 13F filings for Q1 2020.